top of page


Incubate Responds to Maximum Fair Prices Announced for Next 15 Medicare Drugs
WASHINGTON ( November 26) -- Yesterday, the Trump administration announced Maximum Fair Prices (MFPs) for the next 15 Medicare Part D drugs selected for price setting under the Medicare Drug Price Negotiation Program. The new prices take effect in January 2027. Incubate's executive director, John Stanford, issued the following statement in response to the announcement: " Today's announcement is another reminder of the fundamental flaws in existing federal drug-pricing p
Incubate Coalition
Nov 26, 2025


Coming to you from Tokyo on the Making Medicine Podcast
To cap off a successful trip to Japan, Incubate executive director John Stanford sat down with a panel of biotech investors, founders, and industry leaders for an episode of the Making Medicine podcast . John was joined by Shaan Gandhi of Pfizer, Patrick Jordan of NovaQuest Capital Management, Heather Berger of Forge Life Science Partners, and Johannes Fruehauf of BioLabs Global Inc to discuss Japan's emerging biotech hub. Japan's life sciences sector is growing quickly, driv
Incubate Coalition
Nov 21, 2025


Incubate in BioSpace on the FDA and the Federal Government Shutdown
Incubate executive director John Stanford was featured in a BioSpace article by news editor Dan Samorodnitsky on how the ongoing federal government shutdown is affecting the Food and Drug Administration and the broader biopharmaceutical ecosystem. As the shutdown stretches on, Stanford warned that uncertainty and funding lapses are beginning to slow biotech activity and signal risk to the United States' standing as the global center for innovation. He noted that the prolonge
Incubate Coalition
Oct 30, 2025


Talking All Things IP On the Making Medicine Podcast
Incubate executive director John Stanford recently sat down with Joshua Kresh for an episode of the Making Medicine podcast to talk about all things intellectual property (IP). Kresh leads the Institute for Progress & Innovation (IPPI) , where he focuses on strengthening the policies that support scientific progress. IP underpins everything from movies and music to, most importantly, the medicines we rely on. Drug development is slow, risky, and enormously expensive, often t
Incubate Coalition
Oct 23, 2025


Incubate Releases Statement on Trump Administration's "Most Favored Nation" Pricing Deal
WASHINGTON ( Sep 30 ) -- Today, the Trump administration announced its first agreement with a manufacturer to bring most-favored-nation...
Incubate Coalition
Oct 3, 2025
bottom of page


